FIELD: pharmacology.
SUBSTANCE: invention refers to pharmacology, namely to drugs possessing diuretic and creatininuretic activity. What is disclosed is the use of pinocembrin as a diuretic and creatininuretic agent.
EFFECT: using the invention enables increasing the effectiveness of the therapeutic effect and eliminating the occurrence of side effects.
9 cl, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
USE OF DIHYDROQUERCETIN AS A DIURETIC, SALURETIC AND CREATININURETIC AGENT | 2022 |
|
RU2802874C1 |
USE OF HYPEROZIDE AS A DIURETIC, SALURETIC AND CREATININURETIC AGENT | 2022 |
|
RU2802832C1 |
USE OF PINOSTROBIN AS DIURETIC AND CREATINURETIC AGENT | 2023 |
|
RU2816948C1 |
USE OF QUERCETIN AS A DIURETIC, SALURETIC AND CREATININURETIC AGENT | 2022 |
|
RU2802833C1 |
USE OF PATULITRIN AS A DIURETIC | 2022 |
|
RU2807938C1 |
USE OF OREGANOL A WITH DIURETIC ACTIVITY | 2022 |
|
RU2802873C1 |
COMBINED MEDICATION FOR TREATMENT OF ARTERIAL HYPERTENSION IN PATIENTS WITH DIABETES MELLITUS | 2012 |
|
RU2558099C2 |
DIURETIC | 2016 |
|
RU2619348C1 |
HERBAL REMEDY WITH DIURETIC AND NATRIURETIC ACTIVITY FOR THE PREVENTION AND TREATMENT OF DISEASES OF THE URINARY SYSTEM | 2022 |
|
RU2791782C1 |
METHOD OF URINARY NORMALISATION IN RENAL MALFUNCTION | 2004 |
|
RU2367442C2 |
Authors
Dates
2024-07-16—Published
2023-12-01—Filed